- Company Overview for AVEO PHARMA LIMITED (06456614)
- Filing history for AVEO PHARMA LIMITED (06456614)
- People for AVEO PHARMA LIMITED (06456614)
- More for AVEO PHARMA LIMITED (06456614)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
19 Dec 2024 | CS01 | Confirmation statement made on 18 December 2024 with no updates | |
11 Dec 2024 | CH01 | Director's details changed for Michael Bailey on 11 December 2024 | |
11 Dec 2024 | CH01 | Director's details changed for Danielle Holland on 11 December 2024 | |
20 Sep 2024 | AA | Accounts for a dormant company made up to 31 December 2023 | |
20 Dec 2023 | CS01 | Confirmation statement made on 18 December 2023 with no updates | |
05 Oct 2023 | PSC08 | Notification of a person with significant control statement | |
05 Oct 2023 | PSC07 | Cessation of Aveo Pharmaceuticals, Inc. as a person with significant control on 19 January 2023 | |
22 Sep 2023 | AA | Accounts for a dormant company made up to 31 December 2022 | |
11 Apr 2023 | AD01 | Registered office address changed from 2 Temple Back East Temple Quay Bristol Avon BS1 6EG to 5th Floor Halo Counterslip Bristol BS1 6AJ on 11 April 2023 | |
23 Mar 2023 | AP01 | Appointment of Danielle Holland as a director on 23 February 2023 | |
23 Mar 2023 | TM01 | Termination of appointment of Erick Lucera as a director on 23 February 2023 | |
19 Dec 2022 | CS01 | Confirmation statement made on 18 December 2022 with no updates | |
27 Sep 2022 | AA | Accounts for a dormant company made up to 31 December 2021 | |
11 Jan 2022 | AAMD | Amended accounts for a dormant company made up to 31 December 2020 | |
11 Jan 2022 | AAMD | Amended accounts for a dormant company made up to 31 December 2019 | |
23 Dec 2021 | CS01 | Confirmation statement made on 18 December 2021 with no updates | |
17 Dec 2021 | CH01 | Director's details changed for Michael Bailey on 1 March 2020 | |
02 Nov 2021 | AP01 | Appointment of Erick Lucera as a director on 1 November 2021 | |
02 Nov 2021 | TM01 | Termination of appointment of Michael Needle as a director on 1 November 2021 | |
30 Sep 2021 | AA | Accounts for a dormant company made up to 31 December 2020 | |
16 Mar 2021 | CS01 | Confirmation statement made on 18 December 2020 with no updates | |
19 Oct 2020 | AA | Accounts for a dormant company made up to 31 December 2019 | |
05 May 2020 | PSC05 | Change of details for Aveo Pharmaceuticals, Inc. as a person with significant control on 5 May 2020 | |
20 Dec 2019 | CS01 | Confirmation statement made on 18 December 2019 with updates | |
04 Oct 2019 | AA | Accounts for a dormant company made up to 31 December 2018 |